BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 6654158)

  • 1. [Metabolism and ultrastructure of the myocardium in protection of the heart against ischemia using an ozonized cardioplegic solution].
    Korolev BA; Boiarinov GA; Monakhov AN; Shvets NA; Peretiagin SP
    Grudn Khir; 1983; (6):27-31. PubMed ID: 6654158
    [No Abstract]   [Full Text] [Related]  

  • 2. [Evaluation of potentials in using fluorocarbon cardioplegia for protecting the myocardium against ischemia].
    Beloiartsev FF; Kaĭdash AN; Islamov BI; Maevskiĭ EI; Kokoz IuM
    Vestn Akad Med Nauk SSSR; 1986; (6):37-43. PubMed ID: 3751261
    [No Abstract]   [Full Text] [Related]  

  • 3. Retroperfusion of the heart with a solution of glucose, insulin, and potassium during anoxic arrest.
    Lolley DM; Hewitt RL; Drapanas T
    J Thorac Cardiovasc Surg; 1974 Mar; 67(3):364-70. PubMed ID: 4813438
    [No Abstract]   [Full Text] [Related]  

  • 4. Critical importance of ensuring cardioplegic delivery with coronary stenoses.
    Becker H; Vinten-Johansen J; Buckberg GD; Follette DM; Robertson JM
    J Thorac Cardiovasc Surg; 1981 Apr; 81(4):507-15. PubMed ID: 7206757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A proposed "solution" to the cardioplegic controversy.
    Buckberg GD
    J Thorac Cardiovasc Surg; 1979 Jun; 77(6):803-15. PubMed ID: 35662
    [No Abstract]   [Full Text] [Related]  

  • 6. [Ultrastructural characteristics of anti-ischemia protection of intact and hypertrophic myocardium with phosphocreatinine].
    Mogilevskiĭ GM; Sharov VG; Severin VV; Semenovskiĭ ML
    Biull Eksp Biol Med; 1990 Apr; 109(4):408-10. PubMed ID: 2143681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of hypothermic, cardioplegic protection of the global ischemic canine myocardium.
    Hess ML; Krause SM; Greenfield LJ
    J Thorac Cardiovasc Surg; 1980 Aug; 80(2):293-301. PubMed ID: 6447234
    [No Abstract]   [Full Text] [Related]  

  • 8. [Ultrastructural diagnosis of changes in the human myocardium during protection of the heart with cardioplegic solutions].
    Mogilevskiĭ GM; Krymskiĭ LD; Sharov VG
    Arkh Patol; 1986; 48(11):39-45. PubMed ID: 3827622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Subendocardial ischemia and protection of the myocardium].
    Ann Chir Thorac Cardiovasc; 1977 Oct; 16(4):307-14. PubMed ID: 345939
    [No Abstract]   [Full Text] [Related]  

  • 10. [Protection of the myocardium under experimental conditions and during surgery of the mitral valve in humans].
    Matiushin IF; Boiarinov GA; Shvets NA; Dobrotin SS
    Vestn Akad Med Nauk SSSR; 1983; (5):84-91. PubMed ID: 6868811
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of perfusion volume of the Custodiol solution on the efficiency of cardioplegia in experiment].
    Zhidkov IL; Belianko IE; Sitnichenko NV; Paliulina MV; Laptiĭ AV
    Anesteziol Reanimatol; 2008; (5):42-7. PubMed ID: 19102231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced myocardial protection during ischemic arrest. Oxygenation of a crystalloid cardioplegic solution.
    Bodenhamer RM; DeBoer LW; Geffin GA; O'Keefe DD; Fallon JT; Aretz TH; Haas GS; Daggett WM
    J Thorac Cardiovasc Surg; 1983 May; 85(5):769-80. PubMed ID: 6843158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of the pH of cardioplegic solution on postarrest myocardial preservation.
    Nugent WC; Levine FH; Liapis CD; LaRaia PJ; Tsai CH; Buckley MJ
    Circulation; 1982 Aug; 66(2 Pt 2):I68-72. PubMed ID: 7083549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved myocardial protection with perfluorocarbon cardioplegia.
    Gardner TJ; Flaherty JT; Kanter KR; Magovern GJ
    Prog Clin Biol Res; 1983; 122():405-17. PubMed ID: 6878379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Protection of the myocardium during heart transplantation].
    Kazakov EN; Kobakhidze EA; Obukhov VA; Ryklin VA; Minchenko BI
    Vestn Akad Med Nauk SSSR; 1981; (10):31-7. PubMed ID: 7032113
    [No Abstract]   [Full Text] [Related]  

  • 16. Glucose substrate in myocardial protection.
    Salerno TA; Wasan SM; Charrette EJ
    J Thorac Cardiovasc Surg; 1980 Jan; 79(1):59-62. PubMed ID: 7350389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of glucose-containing solutions on ischemic myocardium.
    Wittnich C; Peniston C; Salerno TA
    Ann Chir Gynaecol; 1987; 76(1):77-83. PubMed ID: 3592562
    [No Abstract]   [Full Text] [Related]  

  • 18. Protection of regional myocardium with blood cardioplegia following chronic coronary occlusion.
    Laschinger JC; Cunningham JN; Catinella FP; Baumann FG; Nathan IM; Spencer FC
    Curr Surg; 1982; 39(5):323-6. PubMed ID: 7172731
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effects of various forms of myocardial protection on cardiac function, metabolism, and blood flow (author's transl)].
    Klooker P; Hilse B; Mittmann U; Saggau W; Tanzeem A; Weckler GJ
    Chir Forum Exp Klin Forsch; 1980; ():285-90. PubMed ID: 7389467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship between myocardial temperature and recovery after experimental cardioplegic arrest.
    Rosenfeldt FL
    J Thorac Cardiovasc Surg; 1982 Nov; 84(5):656-66. PubMed ID: 7132405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.